Notizia - Recent Pharma, Healthcare and Biotech Happenings

Vertex Pharmaceuticals recently has announced the acquisition of Semma Therapeutics for USD 950 million in cash. Vertex Pharmaceuticals, aimed at creating therapies for life-threatening diseases, like cystic fibrosis, has signed a definitive agreement with Semma therapeutics, working to bring in the Healthcare market a new innovative treatment option for the diabetes patient pool. Surveys revealed that approximately 1.25 million Americans are living with Type 1 diabetes. And by 2050, 5 million people are expected to be diagnosed with Type 1 diabetes. Semma has successfully advanced in producing large quantities of functional human pancreatic beta cells to t...